Naive CD8+ T cells can be activated via dendritic cell 'cross-priming' of antigens obtained exogenously. Dendritic cells cannot cross-prime, however, after systemic activation in vivo, potentially contributing to immunosuppression associated with severe infections.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial
Journal of Translational Medicine Open Access 21 April 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Heath, W.R. et al. Immunol. Rev. 199, 9–26 (2004).
Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C. & Amigorena, S. Annu. Rev. Immunol. 20, 621–667 (2002).
Wilson, N.S. et al. Nat. Immunol. 7, 165–172 (2006).
Pozzi, L.A., Maciaszek, J.W. & Rock, K.L. J. Immunol. 175, 2071–2081 (2005).
Yewdell, J.W. & Hill, A.B. Nat. Immunol. 3, 1019–1025 (2002).
Yewdell, J.W. & Haeryfar, S.M. Annu. Rev. Immunol. 23, 651–682 (2005).
Pierre, P. Immunol. Rev. 207, 184–190 (2005).
Herter, S. et al. J. Immunol. 175, 891–898 (2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hickman-Miller, H., Yewdell, J. Youth has its privileges: maturation inhibits DC cross-priming. Nat Immunol 7, 125–126 (2006). https://doi.org/10.1038/ni0206-125
Issue Date:
DOI: https://doi.org/10.1038/ni0206-125
This article is cited by
-
Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial
Journal of Translational Medicine (2020)
-
Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy
Cancer Immunology, Immunotherapy (2013)